Skip to main content
Equibles
ISRG logo

ISRG · Intuitive Surgical Inc · Metrics

Track ISRG — free

Use ISRG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ISRG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$436.04 +2.86 (+0.66%)
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$153.03B
Shares
353.28M
Volume · Oct 20 650.35K Avg daily vol (3M) 2.63M

ISRG metrics

91 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$433.18
Market cap
$153.03B

Price action

20 metrics
Price change (1W)
+1.3%
Price change (30D)
+7.9%
Price change (3M)
+22.7%
Price change (6M)
-7.0%
Price change (YTD)
-23.5%
Price change (1Y)
-2.9%
Trailing year
Price change (5Y)
+28.8%
52-week high
$592.85
52-week low
$332.02
Change from 52-week high
-26.9%
Change from 52-week low
+30.5%
Annualized volatility
36.8%
Annualized volatility (3M)
33.0%
Beta
0.9
RSI (14D)
67.7
Price vs SMA 50
+10.3%
Price vs SMA 200
-1.3%
Avg volume (3M)
2.63M
Relative volume
1.0
Average dollar volume
$997.78M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
353.28M

Valuation

12 metrics
P / E (TTM)
49.7
Trailing earnings · reciprocal yield 2.0%
PEG ratio
1.9
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
13.7×
reciprocal yield 7.3%
P / book
8.3
reciprocal yield 12.1%
FCF yield
2.1%
TTM · current market cap
Buyback yield
2.4%
P / FCF
46.8
reciprocal yield 2.1%
P / operating cash flow
40.7
reciprocal yield 2.5%
Earnings yield
2.1%

Historical valuation

8 metrics
P / E historical average (3Y)
69.8×
reciprocal yield 1.4%
P / E historical average (5Y)
68.1×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-16

Profitability

9 metrics
Gross margin
66.7%
Operating margin
31.3%
Trailing 12 months
Net margin
28.4%
Gross profit (TTM)
$7.36B
Operating profit (TTM)
$3.45B
Net income (TTM)
$3.14B
Trailing 12 months
Diluted EPS (TTM)
$8.71
FCF margin
29.2%
Effective tax rate
17.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$30.67
Gross profit per diluted share (TTM)
$20.45
Operating profit per diluted share (TTM)
$9.60
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$8.73
Operating cash flow per diluted share (TTM)
$10.31
Free cash flow per diluted share (TTM)
$8.96
Capital expenditures per diluted share (TTM)
$1.34
R&D per diluted share (TTM)
$3.93
Stock compensation per diluted share (TTM)
$2.30
Book value per share
$50.19

Growth

11 metrics
Revenue growth YoY
+18.5%
Year over year
Net income growth YoY
+24.3%
Revenue (TTM)
$11.03B
Trailing 12 months
EPS growth YoY
+26.5%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+17.4%
Revenue CAGR (5Y)
+18.2%
EPS CAGR (3Y)
+29.2%
EPS CAGR (5Y)
+21.8%
FCF CAGR (3Y)
+37.5%
FCF CAGR (5Y)
+16.9%

Quality

14 metrics
Return on equity
17.3%
Return on assets
15.0%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
—
Free cash flow (TTM)
$3.22B
Quick ratio
3.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$5.22B
Latest balance sheet
Cash & equivalents
$2.76B
Total assets
$20.88B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.71B
Capital expenditures (TTM)
$483.80M
R&D (TTM)
$1.41B
SG&A (TTM)
$2.49B
Stock compensation (TTM)
$826.20M
R&D / revenue
12.8%
Stock compensation / revenue
7.5%

Ownership (13F)

3 metrics
13F filers
2,269
13F filer change QoQ
-57
Institutional ownership
89.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.9%

Short interest

3 metrics
Short interest
2.1%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.98M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1035267 CUSIP 46120E602 13F (30d) 374 filings 360 filers Visit website Investor relations